Ticker brief
VBIO
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
37
authors 14d
2
crowd 14d
+0.7σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-28 · now +0.20 (−1 bearish … +1 bullish)
Who spoke2
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @SuperDuperInvst | C | -0.99 | 36 | +0.55 |
| @AccesswireNews | C | · | 1 | -0.25 |
Recent signals30of 37 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @SuperDuperInvst | +0.20 | Notes FTFT's reverse split and 200% after-hours move while hoping VBIO follows. | · | tweet ↗ |
| 2026-08-27 | @SuperDuperInvst | +0.45 | Discloses continued VBIO ownership despite a collapse and retains a bullish drug-pipeline thesis. | · | tweet ↗ |
| 2026-08-27 | @SuperDuperInvst | +0.45 | Compares VBIO's expected post-split float with DFNS's prior post-split rally. | · | tweet ↗ |
| 2026-08-27 | @SuperDuperInvst | -0.35 | Company announces a 1-for-25 reverse split to regain Nasdaq bid-price compliance. | · | tweet ↗ |
| 2026-08-27 | @AccesswireNews | -0.25 | Valion Bio announced a reverse stock split. | · | tweet ↗ |
| 2026-08-26 | @SuperDuperInvst | +0.65 | Presents a high-risk short-term upside scenario for VBIO. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.80 | Long-term bullish framework based on activist influence, drug potential and expected commercialization. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.10 | Reports CEO termination and a preferred-stock financing agreement with 3i LP. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.25 | Recaps government-funded Entolimod safety and therapeutic studies with data expected in early fall. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.00 | Reports a House committee directive on countermeasures while noting VBIO was not specifically named. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.65 | Bullish interpretation of an S-1 cancellation as reduced dilution risk and possible funding or buyout progress. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.30 | Views VBIO's biodefense work as potentially relevant to national-defense readiness. | · | tweet ↗ |
| 2026-08-24 | @SuperDuperInvst | +0.70 | Predicts a strong weekly rise conditional on a $0.17 close. | · | tweet ↗ |
| 2026-08-24 | @SuperDuperInvst | +0.75 | Speculates that acquisition interest could trigger a bidding war and sharp rise. | · | tweet ↗ |
| 2026-08-24 | @SuperDuperInvst | +0.80 | Expects good news and tight ownership to generate a major short squeeze. | · | tweet ↗ |
| 2026-08-24 | @SuperDuperInvst | +0.00 | Reports a same-day SEC filing without explaining its contents. | · | tweet ↗ |
| 2026-08-24 | @SuperDuperInvst | +0.45 | Reports withdrawal of an S-1 and interprets it as removing near-term dilution risk. | · | tweet ↗ |
| 2026-08-24 | @SuperDuperInvst | +0.60 | Speculates that major news could drive a rebound above $1. | · | tweet ↗ |
| 2026-08-24 | @SuperDuperInvst | +0.85 | Presents a speculative buyout and strategic-investment thesis for VBIO. | · | tweet ↗ |
| 2026-08-23 | @SuperDuperInvst | +0.80 | Strongly advocates that TENX acquire VBIO, while noting TENX's failed Phase 3 trial. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.65 | Speculates a sale or asset deal could lift VBIO from $0.12 to $1-$5, citing HOWL as a model. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.70 | Suggests Tesla-related Neuralink should acquire VBIO for its bio-defense opportunity. | · | tweet ↗ |
| 2026-08-20 | @SuperDuperInvst | -0.35 | Questions who sold heavily after a sharp spike and expresses suspicion about the decline. | · | tweet ↗ |
| 2026-08-20 | @SuperDuperInvst | +0.65 | Speculates positively about a buyout and large long-term drug-sales potential. | · | tweet ↗ |
| 2026-08-20 | @SuperDuperInvst | +0.55 | Speculates that avoiding a reverse split may precede a catalyst and expects post-split upside. | · | tweet ↗ |
| 2026-08-19 | @SuperDuperInvst | +0.60 | Speculates that VBIO could explore a sale or receive a buyout offer, citing MRNA's surprise move. | · | tweet ↗ |
| 2026-08-19 | @SuperDuperInvst | +0.65 | Expects a single major event such as a buyout could drive substantial upside. | · | tweet ↗ |
| 2026-08-19 | @SuperDuperInvst | +0.85 | Accumulate VBIO on dips near $0.13 for a potential move to $0.30-$0.75. — Explicit accumulation with entry context and upside targets. | · | tweet ↗ |
| 2026-08-19 | @SuperDuperInvst | +0.60 | Expects continued government funding and possible stockpiling orders for VBIO. | · | tweet ↗ |
| 2026-08-19 | @SuperDuperInvst | +0.65 | Claims linked information signals enormous value and future potential. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.